For some reason, I put OCC in my 2020 stock tip as one of four (likely the fourth?). Am trying to work out why.
The field: novel collagen medical devices and cellular therapies for the repair and regeneration of human tendons, bone, nerve and cartilage defects; is large, for sporting and especially degeneration associated with ageing and side-effects of other interventions.
(Neuropathic degeneration/ repair looms large in my view; it is one of the really pressing issues)